Cargando…
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
Use of estrogen or estrogen / progestin combination was an approved regimen for menopausal hormonal therapy (MHT). However, more recent patient-centered studies revealed an increase in the incidence of breast cancer in women receiving menopausal hormone therapy with estrogen plus progestin rather th...
Autores principales: | Nair, Hareesh B., Santhamma, Bindu, Krishnegowda, Naveen K., Dileep, Kalarikkal V., Nickisch, Klaus J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806908/ https://www.ncbi.nlm.nih.gov/pubmed/27011208 http://dx.doi.org/10.1371/journal.pone.0151182 |
Ejemplares similares
-
Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs)
por: Chwalisz, Kristof, et al.
Publicado: (2006) -
Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies
por: Wagenfeld, Andrea, et al.
Publicado: (2016) -
EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model
por: Nair, Hareesh B., et al.
Publicado: (2019) -
New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
por: Woźniczka, Magdalena, et al.
Publicado: (2021) -
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
por: Singhal, Hari, et al.
Publicado: (2017)